Literature DB >> 6288551

Continuous production of anti-host IgG antibodies contained in circulating IgG-anti-IgG complexes.

S A Grace, C J Elson.   

Abstract

Weekly injection with antibody-coated pertussis led to the chronic production of serum complexes in mice. Mice bearing one allotype. Iga, received spleen cells from a congenic strain bearing another allotype, Igb, and weekly injections with Iga-coated pertussis. The serum complexes from these mice and from those receiving challenges alone were separated by ultracentrifugation at neutral and acid pH on sucrose density gradients and their fractions tested for their anti-Iga and Iga content. This revealed the presence of anti-host (Iga) allotype antibodies in fractions from mice that had received Igb cells but not from mice given Iga-coated pertussis alone. Iga allotype was detected in fractions from both groups. It is considered that anti-host allotype antibodies are continuously produced but that they cannot be detected in unfractionated serum because the antibody forms complexes with Iga. These findings are discussed in relation to rheumatoid disease in humans.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288551      PMCID: PMC1555452     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

1.  Gamma globulin complexes in rheumatoid arthritis and certain other conditions.

Authors:  H G KUNKEL; H J MULLER-EBERHARD; H H FUDENBERG; T B TOMASI
Journal:  J Clin Invest       Date:  1961-01       Impact factor: 14.808

2.  Long-term immunoglobulin G production by transplanted thymus cells.

Authors:  H S Micklem; N Anderson; J Ure; H P Jones
Journal:  Eur J Immunol       Date:  1976-06       Impact factor: 5.532

3.  Most IgM-producing cells in the mouse secrete auto-antibodies (rheumatoid factor).

Authors:  D W Dresser
Journal:  Nature       Date:  1978-08-03       Impact factor: 49.962

4.  The suppressive effect of carrier priming on the response to a hapten-carrier conjugate.

Authors:  C J Elson; R B Taylor
Journal:  Eur J Immunol       Date:  1974-10       Impact factor: 5.532

5.  Induction of an IgM anti-(bovine)-IgG response in mice by bacterial lipopolysaccharide.

Authors:  D W Dresser; A M Popham
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

6.  Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis. Partial characterization and relationship to lowered complement levels.

Authors:  R J Winchester; V Agnello; H G Kunkel
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

7.  Determination of IgG antiglobulins in rheumatoid disease using insolubilized human IgG.

Authors:  O D Ilter; M W Turner
Journal:  Clin Exp Immunol       Date:  1973-09       Impact factor: 4.330

8.  Functional half-life of virgin and primed B lymphocytes.

Authors:  C J Elson; K F Jablonska; R B Taylor
Journal:  Eur J Immunol       Date:  1976-09       Impact factor: 5.532

9.  Routine assay for detection of IgG and IgM antiglobulins in seronegative and seropositive rheumatoid arthritis.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Br Med J       Date:  1975-07-26

10.  Autoagglutinin produced by organ fragment cultures of mouse spleen.

Authors:  K F Jablonska
Journal:  Eur J Immunol       Date:  1977-11       Impact factor: 5.532

View more
  8 in total

1.  The specificity of human autoantibodies to IgG: the development of methodology for measuring the specificity of antiglobulin isotypes in rheumatoid and normal sera.

Authors:  R E March; V R Winrow; E J Holborow
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

2.  MRL mice show an age-related impairment of IgG aggregate removal from the circulation.

Authors:  M Field; F M Brennan; R D Melsom; D McCarthy; P Mumford; R N Maini
Journal:  Clin Exp Immunol       Date:  1985-07       Impact factor: 4.330

3.  Clearance and localization of immunoglobulin oligomers in mice with chronic circulating endogenous complexes.

Authors:  S A Grace; F M Brennan
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

4.  Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.

Authors:  C J Elson; S D Carter; B J Cottrell; D G Scott; P A Bacon; T B Wallington
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  Prevalence of anti-Fab antibodies in patients with autoimmune and infectious diseases.

Authors:  J Hassan; C Feighery; B Bresnihan; A Whelan
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

6.  Clearance and organ localization of particles and soluble complexes in mice with circulating complexes.

Authors:  S D Carter; F M Brennan; S A Grace; C J Elson
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

7.  Isolation and analysis of complement activating aggregates from synovial fluid of patients with rheumatoid arthritis using monoclonal anti-C3d antibodies.

Authors:  A E Bedwell; C J Elson; S D Carter; P A Dieppe; C W Hutton; R Czudek
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

8.  Relationship between non-antigen-specific immunodepression and persisting immune complexes induced by pertussis in mice.

Authors:  S Grace; D M De Villiers; N M Almond; C J Elson
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.